Corrigendum to “Single-chain fragment variable antibody targeting cholecystokinin-B receptor for pain reduction” [Neurobiol. Pain 10 (2021) 100067]
Main Authors: | K.N. Westlund, M.A. Montera, A.E. Goins, S.R.A. Alles, M. Afaghpour-Becklund, R. Bartel, R. Durvasula, A. Kunamneni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | Neurobiology of Pain |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452073X23000144 |
Similar Items
-
Rapid Generation and Molecular Docking Analysis of Single-Chain Fragment Variable (scFv) Antibody Selected by Ribosome Display Targeting Cholecystokinin B Receptor (CCK-BR) for Reduction of Chronic Neuropathic Pain
by: Adinarayana Kunamneni, et al.
Published: (2023-07-01) -
Single-Dose P2 X4R Single-Chain Fragment Variable Antibody Permanently Reverses Chronic Pain in Male Mice
by: Karin N. Westlund, et al.
Published: (2021-12-01) -
Plant-derived natural products targeting ion channels for pain
by: Sachin Goyal, et al.
Published: (2023-01-01) -
The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management
by: Amandine Bernard, et al.
Published: (2021-11-01) -
Editorial: Insights in pain mechanisms 2022
by: Sascha R. A. Alles
Published: (2023-09-01)